Business Description
Amarantus Bioscience Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US02300U2050
Description
Amarantus Bioscience Holdings Inc is a biopharmaceutical company. It is focused on developing therapeutic products for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company's prime therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia. The group's diagnostics division is dedicated to the development and commercialization of neurology diagnostic products. Its diagnostic product, LymPro Test is a blood-based assay to diagnose Alzheimer's disease.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.94 | |||||
| 9-Day RSI | 42.86 | |||||
| 14-Day RSI | 45.59 | |||||
| 12-1 Month Momentum % | -88.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Yield % | -1602400 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AMBS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Amarantus Bioscience Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -4.17 | ||
| Beta | -19.06 | ||
| Volatility % | 74.05 | ||
| 14-Day RSI | 45.59 | ||
| 14-Day ATR ($) | 0.000049 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -88.89 | ||
| 52-Week Range ($) | 0.0001 - 0.0401 | ||
| Shares Outstanding (Mil) | 630.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Amarantus Bioscience Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Amarantus Bioscience Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Amarantus Bioscience Holdings Inc Frequently Asked Questions
What is Amarantus Bioscience Holdings Inc(AMBS)'s stock price today?
The current price of AMBS is $0.00. The 52 week high of AMBS is $0.04 and 52 week low is $0.00.
When is next earnings date of Amarantus Bioscience Holdings Inc(AMBS)?
The next earnings date of Amarantus Bioscience Holdings Inc(AMBS) is .
Does Amarantus Bioscience Holdings Inc(AMBS) pay dividends? If so, how much?
Amarantus Bioscience Holdings Inc(AMBS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers